Korea Research Institute of Bioscience and Biotechnology

Lg Display Co., Ltd.

Other

Samsung Electro-mechanics Co., Ltd.

Seoul National University

Lg Philips Lcd Co., Inc.

Sungkyunkwan University

Snu Rdb Foundation

Korea Airports Corporation

Sang Ho Choi

Kyung Seop Ahn

Sei Ryang Oh

Hyung Won Ryu

Joong Ku Lee

Su Seok Choi

Sang Woo Lee

Hyeong Kyu Lee

Jung Hee Kim

In Sik Shin

Ok Kyoung Kwon

Wan Yi Li

Hang Jin

Byoung Sik Kim

Dong Soo Kim

Ji Won Park

Sang-Woo Lee

Byoung-Mog Kwon

Sei-Ryang Oh

Doo Young Kim

Dong Cho Han

Hyung Jun Cho

Ho Yong Park

Ki Bok Park

Kwang Suk Park

Se Jong Kim

Yu Jin Lee

Lak Shin Jeong

Jeong Hae Kim

Tae Sook Jeong

Nam Chul Ha

Ho Han

Joongku Lee

Jee Hoon Kim

Seung Hyung Kim

Myung Hee Kim

Choon Gon Jang

Jung Won Hwang

Soo Yong Kim

Yoon-Jeong Jeon

Zee-Won Lee

Jin Hyub Paik

Rifatul Widjhati

Fifit Juniarti

Kyung Ku Jang

Seung Hwan Kwon

Jin Hang

Li Wan Yi

Hyun Bin Kwon

Hee Nam Yoon

Rosales Ovares Kattia

Zamora Villalobos Nelson

Hwa Lee

The present invention relates to a cosmetic composition for preventing skin aging and reducing skin wrinkles containing an extract of-The cosmetic composition has an excellent antioxidant effect and exhibits the effect of inhibiting collagenase overexpression and increasing collagen gene expression, and thus can be effectively used for the purposes of preventing skin aging and reducing skin wrinkles.

Cosmetic composition for preventing skin aging and reducing skin wrinkles, comprising Viburnum stellato-tomentosum extract

Proposed is a through type drain pump for a fluid draining apparatus of a fluid pipe. The drain pump includes: a housing formed in a hollow cylindrical shape, the housing being configured such that a fluid inlet port and a fluid outlet port are in communication with each other via a fluid movement path; a rotary shaft having a driving motor, the rotary shaft being rotatably coupled to an output shaft of the driving motor via a coupler; an impeller formed at a lower end of the rotary shaft and configured to be rotated so that the fluid is moved to the fluid outlet port through the fluid movement path; and a mounter mounted at a lower outer side surface of the housing and configured to mount the drain pump on any pipe such that the drain pump is capable of being lifted and inserted into the pipe.

Through-type drain pump for fluid draining apparatus of fluid pipe

Provided is a method for treating a symptom of vibrio infection by using an RTX toxin production inhibitor comprising N-(4-oxo-4H-thieno[3,4-c]chromen-3-yl)-3-phenylprop-2-ynamide having derivatives thereof which can repress (prevent or treat) a symptom of vibrio infection by inhibiting RTX toxin production, other than directly killing vibrio bacteria, to not allow vibrio bacteria to have pathogenicity, and thereby can be an alternative to antibiotics that aim to kill bacteria themselves and thus fundamentally retain the problem of resistance incurrence.

RTX toxin production inhibitor and composition for treating symptom of vibrio infection by using same

A method for inducing an activity of a user's autonomic nervous system is provided. The method includes steps of: (a) on condition that each of the user's reference heart rate information corresponding to each of active states of the user's autonomic nervous system is obtained, an inducing device, if a specific active state of the autonomic nervous system is selected by the user, acquiring first reference heart rate information of the user corresponding to the specific active state of the autonomic nervous system; and (b) the inducing device supporting a first vibration stimulus with a first period corresponding to the first reference heart rate information to be applied to the user, to thereby allow the user's real-time average cardiac interval to be synchronized with the first vibration stimulus.

Apparatus for inducing activity of user's autonomic nervous system and method thereof

The present invention relates to a composition for suppressing chronic obstructive pulmonary disease (COPD) comprising aextract, a fraction thereof, or a compound isolated therefrom and, more particularly, to a pharmaceutical composition for preventing or treating COPD comprising aextract, a fraction thereof, or a compound isolated therefrom; a food composition for preventing or improving COPD, and the compound isolated therefrom. The composition comprising aextract, a fraction thereof, or a compound isolated therefrom, according to the present invention, is not toxic, suppresses the invasion of inflammatory cells into the bronchial tube of a COPD-induced animal model, and effectively suppresses the expression of CXCL-1, TNF-&#x3b1;, or MIP-2. In addition, due to the use of a safety-proven herbal drug as a raw material, the composition of the present invention can resolve various side-effects of existing therapeutic agents for COPD, chronic obstructive bronchitis, chronic bronchiolitis, emphysema, multiple sclerosis, and acute and chronic inflammation, and thus can be effectively used as a composition for preventing, treating and remedying COPD.

Pharmaceutical composition comprisingextract, fraction of same or compound separated from same for preventing or treating chronic obstructive pulmonary disease (COPD)

The present invention relates to a composition for preventing or treating asthma comprising aJ. Poiss. ex Franch extract or a fraction thereof. TheJ. Poiss. ex Franch extract or the fraction thereof according to the present invention does not exhibit toxicity, inhibits the generation of NO, IL-4, IL-5, and IL-13 and the generation of reactive oxygen species in the bronchial tubes, and has significantly induced the alleviation of airway hyperresponsiveness, inhibition of the infiltration of inflammatory cells into the bronchial tubes, and reduction of inflammatory cells in bronchoalveolar lavage fluid in an ovalbumin-induced asthma mouse model. In addition, theJ. Poiss. ex Franch extract or the fraction thereof according to the present invention effectively inhibits the secretion of immunoglobulins in serum, secretion of mucus in the bronchial tubes, and infiltration of inflammatory cells into lung tissue and thus can be usefully used as a safe preparation for preventing and treating asthma.

Pharmaceutical composition for preventing or treating asthma comprisingJ. Poiss. ex Franch extract or fraction thereof

The present invention relates to a pharmaceutical composition and a food composition containingHook. extract or a fraction thereof as an active ingredient for preventing, treating or ameliorating neuroinflammation or neuro-degenerative diseases. TheHook. extract or a fraction thereof according to the present invention is derived from a natural product which has been in use as a natural medicinal ingredient, and as such, has no side effects and inhibits expression of NO, PGE, iNOS and/or COX-2 genes or protein, which are factors associated with inflammation, and is additionally superbly effective for increasing and improving memory and the ability to learn, and thus can be beneficially used to prevent or treat neuroinflammation or neuro-degenerative diseases.

Method for treating neuroinflammation with a pharmaceutical composition containinghook. extract or fraction thereof as active ingredient

Multilingual information guidance system and device are provided. To elaborate, the system may include: at least one information output device configured to display guidance information to a user; and an information provision server connected to the information output device and configured to provide guidance information prepared in one or more languages to the information output device according to a request of the information output device. The information output device may output guidance information prepared in the native language corresponding to nationality information of a user, which is read from an RFID tag in which the nationality information of the user is stored or transmitted from the information provision server.

Multilingual information guidance system and device

There are provided a printed circuit board and a manufacturing method thereof. The printed circuit board includes: a core layer having a cavity provided therein; an electronic component included in the cavity; a conductive partition disposed on a side of the cavity; and insulating layers disposed on and below the core layer.

Noise blocking printed circuit board and manufacturing method thereof

The present invention relates to a pharmaceutical composition for preventing or treating inflammatory diseases or asthma comprising aextract or a fraction thereof as an active ingredient, and a health functional food and a feed additive for preventing or improving inflammatory diseases or asthma comprising the extract or the fraction as an active ingredient.

Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient

The present invention relates to a pharmaceutical composition for preventing and treating cancer which comprises the extracts offruits, leaves, or stems, or the fractions thereof as active ingredients. The extracts offruits, leaves, or stems, or the fractions thereof, according to the present invention, suppress the activity of signal transducer and activator of transcription3 (STAT3) which plays an important role in the growth of a cancer cell line and in the immune function of the human body, and can thus be effectively used in the prevention and treatment of cancers such as colorectal cancer, stomach cancer, prostate cancer, breast cancer, renal cancer, liver cancer, brain tumor, lung cancer, uterine cancer, colorectal cancer, bladder cancer, or pancreatic cancer.

Composition for preventing or treating cancer containing extracts of artocarpus altilis fruits, leaves, or stems, or fractions thereof as active ingredients

The present invention relates to a three-dimensional structure of a complex explored by crystallization of the complex of NanR which is a key pathogenic regulatory protein ofand ManNA6P which is a NanR regulator. Further, the present invention relates to a modified NanR protein, a polynucleotide encoding the protein, a vector including the polynucleotide, and a transformant including the vector. Furthermore, the present invention relates to a method for screening a substance regulating interaction between NanR and the transcriptional control region of nan operon which is a gene cluster regulated by NanR, or a substance regulating interaction between NanR and ManNAc-6P, by designing three-dimensional structure of the complex, and to an antibacterial composition including the screened substance.

Crystal structure of the NanR and ManNAc-6P complex, and uses thereof

The present invention provides a tacking nail connection body which allows a user to clearly recognize a stage for use of a tacking nail and a point in time for charging a tacker. In the tacking nail connection body () in which a plurality of tacking nails are arranged in a line and connected to each other, at least one tacking nail () disposed on a position biased from a central portion of the tacking nail connection body () toward one side includes an indicating member () attached along a length direction of a body part () on a surface of the body part () between a head part () and a tip part () of the tacking nail () and separated from the body part () when the body part () is stuck into lumber.

Tacking nail or tacking pin including a charging time indicating member for tacker

Disclosed herein is a method for selecting a user. A method for selecting a user in a communication system including a base station having M antennas and K users having one receive antenna includes: (a) calculating channel orthogonality between each of the possible users and previously selected users; and (b) selecting users having the largest channel orthogonality calculated at the step (a) among the possible users.

Method for selecting user

A LCD and a fabrication process is presented. An upper substrate is coincidently formed with a red, a green and a blue color filters using phase separation. A compound containing a photopolymeric color filter resin and a liquid crystal are coated on an array substrate and then photopolymerized after formation of the array substrate. A seed layer may be provided on the substrate before the compound is applied. Polymerization of the color filter resin permits simultaneous formation of the upper, color filter substrate and liquid crystal layer.

Liquid crystal display device

Growing community of inventors

Gyeonggi-do, South Korea

Sang Ho Choi